FHIR IG analytics| Package | hl7.fhir.uv.xver-r4.r4b |
| Resource Type | ValueSet |
| Id | ValueSet-R4-v2-0227-for-R4B.json |
| FHIR Version | R4B |
| Source | http://hl7.org/fhir/uv/xver-r4.r4b/0.1.0/ValueSet-R4-v2-0227-for-R4B.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R4-v2-0227-for-R4B |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R4V20227ForR4B |
| Title | Cross-version ValueSet R4.v2.0227 for use in FHIR R4B |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v2-0227|2.9` for use in FHIR R4B. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the value set `http://terminology.hl7.org/ValueSet/v2-0227|2.9` as defined in FHIR R4 in FHIR R4B. The source value set is bound to the following FHIR R4 elements: * Note that all concepts are included in this cross-version definition because no concepts have compatible representations Following are the generation technical comments: FHIR ValueSet `http://terminology.hl7.org/ValueSet/v2-0227|2.9`, defined in FHIR R4 does not have any mapping to FHIR R4B |
No resources found
| CodeSystem | ||
| hl7.fhir.uv.xver-r4.r4b#0.1.0 | v2-0227 | v2 Manufacturers of Vaccines |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R4-v2-0227-for-R4B
This value set expansion contains 55 concepts.
| System | Version | Code | Display |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | AB | Abbott Laboratories |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | AD | Adams Laboratories, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | ALP | Alpha Therapeutic Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | AR | Armour |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | AVB | Aventis Behring L.L.C. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | AVI | Aviron |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | BA | Baxter Healthcare Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | BAH | Baxter Healthcare Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | BAY | Bayer Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | BP | Berna Products |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | BPC | Berna Products Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | CEN | Centeon L.L.C. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | CHI | Chiron Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | CMP | Celltech Medeva Pharmaceuticals |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | CNJ | Cangene Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | CON | Connaught |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | DVC | DynPort Vaccine Company, LLC |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | EVN | Evans Medical Limited |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | GEO | GeoVax Labs, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | GRE | Greer Laboratories, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | IAG | Immuno International AG |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | IM | Merieux |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | IUS | Immuno-U.S., Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | JPN | The Research Foundation for Microbial Diseases of Osaka University |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | KGC | Korea Green Cross Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | LED | Lederle |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MA | Massachusetts Public Health Biologic Laboratories |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MBL | Massachusetts Biologic Laboratories |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MED | MedImmune, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MIL | Miles |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MIP | Bioport Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | MSD | Merck & Co., Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | NAB | NABI |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | NAV | North American Vaccine, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | NOV | Novartis Pharmaceutical Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | NVX | Novavax, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | NYB | New York Blood Center |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | ORT | Ortho-Clinical Diagnostics |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | OTC | Organon Teknika Corporation |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | OTH | Other manufacturer |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | PD | Parkedale Pharmaceuticals |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | PMC | sanofi pasteur |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | PRX | Praxis Biologics |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | PWJ | PowderJect Pharmaceuticals |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | SCL | Sclavo, Inc. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | SI | Swiss Serum and Vaccine Inst. |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | SKB | GlaxoSmithKline |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | SOL | Solvay Pharmaceuticals |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | TAL | Talecris Biotherapeutics |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | UNK | Unknown manufacturer |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | USA | United States Army Medical Research and Material Command |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | VXG | VaxGen |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | WA | Wyeth-Ayerst |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | WAL | Wyeth-Ayerst |
http://terminology.hl7.org/CodeSystem/v2-0227 | 2.9 | ZLB | ZLB Behring |
{
"resourceType": "ValueSet",
"id": "R4-v2-0227-for-R4B",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 0
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r4.r4b"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r4b"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r4b"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R4-v2-0227-for-R4B",
"version": "0.1.0",
"name": "R4V20227ForR4B",
"title": "Cross-version ValueSet R4.v2.0227 for use in FHIR R4B",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents content from `http://terminology.hl7.org/ValueSet/v2-0227|2.9` for use in FHIR R4B.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://terminology.hl7.org/ValueSet/v2-0227|2.9` as defined in FHIR R4\r\nin FHIR R4B.\r\n\r\nThe source value set is bound to the following FHIR R4 elements:\r\n* \r\n\r\nNote that all concepts are included in this cross-version definition because no concepts have compatible representations\r\n\r\nFollowing are the generation technical comments:\r\n\nFHIR ValueSet `http://terminology.hl7.org/ValueSet/v2-0227|2.9`, defined in FHIR R4 does not have any mapping to FHIR R4B",
"compose": {
"include": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"concept": [
{
"code": "AB",
"display": "Abbott Laboratories"
},
{
"code": "AD",
"display": "Adams Laboratories, Inc."
},
{
"code": "ALP",
"display": "Alpha Therapeutic Corporation"
},
{
"code": "AR",
"display": "Armour"
},
{
"code": "AVB",
"display": "Aventis Behring L.L.C."
},
{
"code": "AVI",
"display": "Aviron"
},
{
"code": "BA",
"display": "Baxter Healthcare Corporation"
},
{
"code": "BAH",
"display": "Baxter Healthcare Corporation"
},
{
"code": "BAY",
"display": "Bayer Corporation"
},
{
"code": "BP",
"display": "Berna Products"
},
{
"code": "BPC",
"display": "Berna Products Corporation"
},
{
"code": "CEN",
"display": "Centeon L.L.C."
},
{
"code": "CHI",
"display": "Chiron Corporation"
},
{
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals"
},
{
"code": "CNJ",
"display": "Cangene Corporation"
},
{
"code": "CON",
"display": "Connaught"
},
{
"code": "DVC",
"display": "DynPort Vaccine Company, LLC"
},
{
"code": "EVN",
"display": "Evans Medical Limited"
},
{
"code": "GEO",
"display": "GeoVax Labs, Inc."
},
{
"code": "GRE",
"display": "Greer Laboratories, Inc."
},
{
"code": "IAG",
"display": "Immuno International AG"
},
{
"code": "IM",
"display": "Merieux"
},
{
"code": "IUS",
"display": "Immuno-U.S., Inc."
},
{
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University"
},
{
"code": "KGC",
"display": "Korea Green Cross Corporation"
},
{
"code": "LED",
"display": "Lederle"
},
{
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories"
},
{
"code": "MBL",
"display": "Massachusetts Biologic Laboratories"
},
{
"code": "MED",
"display": "MedImmune, Inc."
},
{
"code": "MIL",
"display": "Miles"
},
{
"code": "MIP",
"display": "Bioport Corporation"
},
{
"code": "MSD",
"display": "Merck & Co., Inc."
},
{
"code": "NAB",
"display": "NABI"
},
{
"code": "NAV",
"display": "North American Vaccine, Inc."
},
{
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation"
},
{
"code": "NVX",
"display": "Novavax, Inc."
},
{
"code": "NYB",
"display": "New York Blood Center"
},
{
"code": "ORT",
"display": "Ortho-Clinical Diagnostics"
},
{
"code": "OTC",
"display": "Organon Teknika Corporation"
},
{
"code": "OTH",
"display": "Other manufacturer"
},
{
"code": "PD",
"display": "Parkedale Pharmaceuticals"
},
{
"code": "PMC",
"display": "sanofi pasteur"
},
{
"code": "PRX",
"display": "Praxis Biologics"
},
{
"code": "PWJ",
"display": "PowderJect Pharmaceuticals"
},
{
"code": "SCL",
"display": "Sclavo, Inc."
},
{
"code": "SI",
"display": "Swiss Serum and Vaccine Inst."
},
{
"code": "SKB",
"display": "GlaxoSmithKline"
},
{
"code": "SOL",
"display": "Solvay Pharmaceuticals"
},
{
"code": "TAL",
"display": "Talecris Biotherapeutics"
},
{
"code": "UNK",
"display": "Unknown manufacturer"
},
{
"code": "USA",
"display": "United States Army Medical Research and Material Command"
},
{
"code": "VXG",
"display": "VaxGen"
},
{
"code": "WA",
"display": "Wyeth-Ayerst"
},
{
"code": "WAL",
"display": "Wyeth-Ayerst"
},
{
"code": "ZLB",
"display": "ZLB Behring"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "AB",
"display": "Abbott Laboratories"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "AD",
"display": "Adams Laboratories, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "ALP",
"display": "Alpha Therapeutic Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "AR",
"display": "Armour"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "AVB",
"display": "Aventis Behring L.L.C."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "AVI",
"display": "Aviron"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "BA",
"display": "Baxter Healthcare Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "BAH",
"display": "Baxter Healthcare Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "BAY",
"display": "Bayer Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "BP",
"display": "Berna Products"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "BPC",
"display": "Berna Products Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "CEN",
"display": "Centeon L.L.C."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "CHI",
"display": "Chiron Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "CMP",
"display": "Celltech Medeva Pharmaceuticals"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "CNJ",
"display": "Cangene Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "CON",
"display": "Connaught"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "DVC",
"display": "DynPort Vaccine Company, LLC"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "EVN",
"display": "Evans Medical Limited"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "GEO",
"display": "GeoVax Labs, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "GRE",
"display": "Greer Laboratories, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "IAG",
"display": "Immuno International AG"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "IM",
"display": "Merieux"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "IUS",
"display": "Immuno-U.S., Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "JPN",
"display": "The Research Foundation for Microbial Diseases of Osaka University"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "KGC",
"display": "Korea Green Cross Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "LED",
"display": "Lederle"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MA",
"display": "Massachusetts Public Health Biologic Laboratories"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MBL",
"display": "Massachusetts Biologic Laboratories"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MED",
"display": "MedImmune, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MIL",
"display": "Miles"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MIP",
"display": "Bioport Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "MSD",
"display": "Merck & Co., Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "NAB",
"display": "NABI"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "NAV",
"display": "North American Vaccine, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "NOV",
"display": "Novartis Pharmaceutical Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "NVX",
"display": "Novavax, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "NYB",
"display": "New York Blood Center"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "ORT",
"display": "Ortho-Clinical Diagnostics"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "OTC",
"display": "Organon Teknika Corporation"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "OTH",
"display": "Other manufacturer"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "PD",
"display": "Parkedale Pharmaceuticals"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "PMC",
"display": "sanofi pasteur"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "PRX",
"display": "Praxis Biologics"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "PWJ",
"display": "PowderJect Pharmaceuticals"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "SCL",
"display": "Sclavo, Inc."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "SI",
"display": "Swiss Serum and Vaccine Inst."
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "SKB",
"display": "GlaxoSmithKline"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "SOL",
"display": "Solvay Pharmaceuticals"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "TAL",
"display": "Talecris Biotherapeutics"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "UNK",
"display": "Unknown manufacturer"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "USA",
"display": "United States Army Medical Research and Material Command"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "VXG",
"display": "VaxGen"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "WA",
"display": "Wyeth-Ayerst"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "WAL",
"display": "Wyeth-Ayerst"
},
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0227",
"version": "2.9",
"code": "ZLB",
"display": "ZLB Behring"
}
]
}
}